About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug “Ninlaro” Receives USFDA Approval for Treating Multiple Myeloma

by Reshma Anand on November 23, 2015 at 4:10 PM
Font : A-A+

New Drug “Ninlaro” Receives USFDA Approval for Treating Multiple Myeloma

Takeda Oncology, a drug firm has received USFDA approval for its new drug called "ninlaro" as part of the combination treatment for Multiple Myeloma.

The drug ixazomib marketed as ninlaro can be administered along with Celgene's Revlimid (lenalidomide) and dexamethasone to treat patients who have received at least one prior therapy. Ninlaro is a type of cancer drug called a proteasome inhibitor which works by blocking enzymes from multiple myeloma cells, hindering their ability to grow and survive.

Advertisement


Study participants received either Ninlaro in combination with lenalidomide and dexamethasone or placebo plus lenalidomide and dexamethasone. The results showed that participants taking the once-weekly regimen lived for an average of 20.6 months compared to 14.7 months in the group receiving a placebo plus Revlimid and dexamethasone, with a tolerable safety profile.

"The introduction of Ninlaro marks an important step forward, as its efficacy and safety profile - coupled with its completely oral administration - potentially can reduce some logistical burdens, and help enable patients to reap the full benefits of this sustainable therapy," noted Christophe Bianchi, president of Takeda Oncology.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity Multiple Myeloma 

Most Popular on Medindia

Find a Hospital Indian Medical Journals How to Reduce School Bag Weight - Simple Tips Sanatogen Drug Interaction Checker Loram (2 mg) (Lorazepam) Drug Side Effects Calculator Iron Intake Calculator Blood Pressure Calculator Diaphragmatic Hernia
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE

×

New Drug “Ninlaro” Receives USFDA Approval for Treating Multiple Myeloma Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests